Asset-like acquisitions
|
|
- Bertram Jenkins
- 6 years ago
- Views:
Transcription
1 Asset-like acquisitions Valuation considerations 17 March 2015
2 Asset-like acquisitions What do we mean by an Asset-like acquisition? An acquisition of a product or group of products that meets the definition of a business and recorded as a business combination pursuant to ASC 805.but, goodwill is NOT anticipated as the forecasts do not include revenue or earnings from unidentified future products How is the expectation of minimal/no goodwill achieved in an asset-like acquisition? Page 2
3 Asset-like acquisitions Taxable transaction (Asset deal) Buyer receives stepped-up tax basis on asset and presumably pays for this within the agreed upon price Book to tax differences are minimal as are potential deferred taxes Non-taxable transaction (Stock deal) Buyer does not receive a stepped-up tax basis and presumably pays less as no tax shield is available Book to tax differences are substantial as are potential deferred taxes Page 3
4 Asset-like acquisitions Example: Purchase of Developed technology for $50M Opening balance sheet - Taxable Transaction Opening balance sheet - Non-taxable Transaction Assets Assets Developed Technology 50 Developed Technology 50 Economic? Goodwill 0 Goodwill 15 Total Assets 50 Total Assets 65 Liabilities Liabilities DTL 0 DTL 15 Equity 50 Equity 50 Total Liabilities & Equity 50 Total Liabilities & Equity 65 Page 4
5 Day 2 issues & challenges Valuation considerations 17 March 2015
6 Day 2 issues & challenges Goodwill impairment Reporting unit versus IPR&D testing dates Interim testing procedures Cost structure in PPA versus cost structure in impairment analysis Allocation of corporate costs Changes to cash flows forecasts prior to initial test date Measurement period adjustment or potential impairment Discount rates Size and company specific risk premiums IPR&D impairment Testing based on therapeutic area, geography, launch date, etc. Change of indication for existing IPR&D product Milestones/royalties related to prior acquisitions versus licenses Cost structure in PPA versus cost structure in impairment analysis Capital asset charges post acquisition Page 6
7 Day 2 issues & challenges Sources of goodwill Future technology/customers Synergies not attributable to intangible assets Sale of a business operation (carve out) Allocation of existing goodwill Contingent consideration Methodology Discount rate Page 7
8 Tax synergies Purchase price allocation Tax structuring (e.g. NOLs, IP migration, inversions) has become a more common aspect of the deals in recent years. The benefits of the tax structuring are typically considered (i.e. modeled out) in deal models and become a new source of synergy. Tax synergies considerations in purchase price allocation Inversion deals or inverted companies - typically modeled out as the tax benefit resulting from shielding of the US profits (generally the buyer s profits) by an inter-company loan set up to finance the deal Typically considered market-participant assumption if explicitly included in the deal model (in other words, something the buyer paid for ) There is a debate whether tax synergies should be included in the intangible asset valuations when these are driven by the tax structure of the buyer as opposed to deal structure Page 8
9 Tax synergies Purchase price allocation In inversion deals, unlike operating synergies, tax synergies are not assumed to be part of the asset valuation as realization of these synergies would not be possible outside an inversion deal structure, which is a stock deal As a result, the value of tax synergies is typically carved out of the deal model and overall purchase price is split into the operating value and tax synergies Since the tax synergies assumptions are not included in the valuation of intangible assets, its value ends up in goodwill Page 9
10 Tax synergies Goodwill allocation and impairment test Initial goodwill allocation Because goodwill is assigned to the reporting units that are expected to benefit from the synergies of the combination, it is possible that the acquirer may assign a portion of the goodwill related to tax synergies to its own reporting units In the case of multiple reporting units, relative pre-tax profit or EBIT may be a reasonable allocation methodology Goodwill impairment test Incorporating tax synergies in Day 2 valuations of the reporting units present a modeling challenge Extending initial model assumptions (i.e., refinancing or incremental leverage assumptions) Assigning the benefit of future tax optimization strategies to the individual reporting unit models Page 10
11 Day 2 issues & challenges GAAP vs Non GAAP adjustments Amortization of inventory step up Stock-based compensation expense Impairment of goodwill and intangibles Acquisition, integration and restructuring expenses Amortization of intangible assets Upfront and development milestone costs Contingent consideration fair value adjustments Non-recurring expenses Legal expenses Impact of currency fluctuations Adjust tax expense to cash taxes Page 11
12 Inventory Valuation considerations 17 March 2015
13 Inventory introduction Inventory is comprised of several different categories: Ready to be sold in the normal course of business (finished goods) In production for future sale (work-in-process or WIP) Used in the production of goods to be sold (raw materials) Valuation classification may differ from accounting or balance sheet classification. In certain cases (e.g. outsourced manufacturing, API is classified as raw materials on the balance sheet but would be treated as work in process in the valuation and stepped-up because value has been added in the manufacturing of the API) Page 13
14 Inventory valuation introduction The fair values for work-in-process (WIP) and finished goods inventory acquired in a business combination are generally measured using a net realizable value computation. The net realizable value computation takes the expected sales price of the inventory reduced for all costs expected to be incurred in the completion and disposition of the inventory as well as a profit on those costs. Raw materials at current replacement cost The size of the inventory step up is directly correlated to the profitability of the business/product over the period over which the inventory is expected to be disposed of Page 14
15 Inventory valuation process Estimate selling price Gross up method versus bottom-up build up Estimate costs to complete and disposition costs Inclusion of indirect operating expenses or disposition costs (e.g. G&A to support manufacturing or sales functions) Inclusion of R&D expenses and royalties Estimate profit on the remaining costs Identification of expenses and efforts for which the seller is not generally entitled to a profit (e.g. 3 rd party royalties) Normalized profit versus profit over the expected period of inventory disposition Page 15
16 Inventory additional valuation considerations Pre-approval inventory in the life sciences industry, inventory acquired before a therapy is approved is often expensed to R&D. If the target is acquired shortly after the therapy has been approved, expensed inventory that is expected to be sold will need to be fair valued. Outsourced manufacturing while the book value of inventory for companies that outsource their manufacturing process may represent the arm s length price for the contract manufacturing services, it does not reflect the value of the intellectual property inherent in the product. Therefore, inventory manufactured by a contract manufacturer will typically be stepped-up to the extent any IP is relied upon in the manufacturing process/ resulting product. Page 16
17 Inventory additional valuation considerations Large amount of acquired inventory typical in large molecule/ biotechnology therapeutics where the amount of acquired inventory is expected to last several years after the acquisition, in extreme cases, throughout the expected life of the corresponding intangible asset. The inventory valuation in this case will look more akin to intangible asset valuation with expected profit attributable to the incurred costs to be discounted at rates close to intangible asset discount rate. Royalty charges technology royalty is applied in the WIP calculations to represent hypothetical royalty a third party would need to incur for access to the intellectual property in order to complete the inventory Page 17
18 Inventory step-up in intangible assets valuation When valuing intangible assets acquired in a business combination where there is also an inventory step-up, the profit included in the inventory step-up must be removed from the projected financial information of the intangible asset so that the profit is not recognized more than once. The full amount of the inventory step-up must be removed from the projections of the intangible asset over the time period in which the acquired inventory is expected to turn. Page 18
19 Inventory step-up in technology asset valuation - example Step-up adjustment included Remove total inventory stepup from gross profit over the expected period of inventory For the years ending 31 Dec disposition (USD in 000s) 2015E 2016E 2017E 2018E 2019E Revenue associated with technology 100, , , , ,410 Cost of goods sold (20,000) (22,000) (24,200) (26,620) (29,282) Inventory step up (10,000) (11,000) (12,100) (13,310) - Gross profit 70,000 77,000 84,700 93, ,128 SG&A (25,000) (27,500) (30,250) (33,275) (36,603) Research and development (8,000) (7,750) (1,314) (986) (986) EBITDA 37,000 41,750 53,136 58,909 79,540 Depreciation (tax) (40) (110) (185) (258) (341) Pretax income (loss) 36,960 41,640 52,952 58,651 79,199 Income tax expense (13,860) (15,615) (19,857) (21,994) (29,700) Net income (loss) 23,100 26,025 33,095 36,657 49,499 Add: Depreciation (tax) Less: Return of fixed assets (40) (110) (185) (258) (341) Less: Contributory assets' charge (357) (392) (431) (475) (1,044) After-tax cash flow 22,743 25,633 32,663 36,183 48,455 Present value factor 11.0% Present value of after-tax cash flow 21,214 21,539 24,727 24,677 29,772 Present value discrete cash flows 329,923 Remove expected inventory sales price from the revenue base used to calculate contributory asset charges Page 19
20 Inventory step-up in technology asset valuation - example Step-up adjustment excluded For the years ending 31 Dec (USD in 000s) 2015E 2016E 2017E 2018E 2019E Revenue associated with technology 100, , , , ,410 Cost of goods sold (20,000) (22,000) (24,200) (26,620) (29,282) Inventory step up Gross profit 80,000 88,000 96, , ,128 SG&A (25,000) (27,500) (30,250) (33,275) (36,603) Research and development (8,000) (7,750) (1,314) (986) (986) EBITDA 47,000 52,750 65,236 72,219 79,540 Depreciation (tax) (40) (110) (185) (258) (341) Pretax income (loss) 46,960 52,640 65,052 71,961 79,199 Income tax expense (17,610) (19,740) (24,394) (26,986) (29,700) Net income (loss) 29,350 32,900 40,657 44,976 49,499 Add: Depreciation (tax) Less: Return of fixed assets (40) (110) (185) (258) (341) Less: Contributory assets' charge (713) (784) (863) (949) (1,044) After-tax cash flow 28,637 32,115 39,794 44,027 48,455 Present value factor 11.0% Present value of after-tax cash flow 26,711 26,987 30,126 30,027 29,772 Present value discrete cash flows 351,616 Page 20
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 8-K/A
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest
More informationConsolidated Statement of Profit or Loss (in million Euro)
Consolidated Statement of Profit or Loss (in million Euro) Q1 2016 Q1 2017 % change Revenue 603 588-2.5% Cost of sales (408) (396) -2.9% Gross profit 195 192-1.5% Selling expenses (84) (86) 2.4% Research
More informationConsolidated Statement of Profit or Loss (in million Euro)
Consolidated Statement of Profit or Loss (in million Euro) Q3 2015 Q3 2016 % change 9m 2015 9m 2016 % change Revenue 661 625-5.4% 1,974 1,873-5.1% Cost of sales (453) (415) -8.4% (1,340) (1,239) -7.5%
More informationCBI - 10th Life Sciences Accounting and Reporting Congress. March 18, 2014
CBI 0th Life Sciences Accounting and Reporting Congress March 8, 204 Introductions Brent Sabatini Director Technical Accounting & Controls Prateep Menon, CFA Principal Life Sciences Advisory Services One
More informationAGILENT TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) (Unaudited)
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) Twelve Months Ended October 31, Percent 2002 2001 Inc/(Dec) Orders $ 6,013 $ 6,414 (6%) Net revenue $ 6,010 $ 8,396
More informationNon-GAAP Information 5/3/2018
5/3/2018 Use of Non-GAAP Financial Information: The Company believes that non-gaap performance measures, which management uses in evaluating the Company's business, may provide users of the Company's financial
More informationFLEX RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (In thousands, except per share amounts)
FLEX RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (In thousands, except per share amounts) Q1 FY18 Q2 FY18 Q3 FY18 Q4 FY18 Q1 FY19 Q2 FY19 GAAP gross profit $ 406,932 6.8% $ 393,325 6.3% $ 446,328
More informationAGILENT TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) (Unaudited)
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (In millions, except per share amounts) Three Months Ended January 31, Percent 2003 2002 Inc/(Dec) Orders $ 1,358 $ 1,465 (7%) Net revenue $ 1,412 $ 1,426
More informationON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data)
UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data) Revenue $ 1,503.1 $ 1,541.7 $ 1,377.5 $ 5,878.3 $ 5,543.1 Cost of revenue (exclusive of amortization shown below) 933.4
More informationCoherent, Inc. Consolidated Statement of Operations - GAAP
Consolidated Statement of Operations - GAAP (In thousands except percentages and per share data, unaudited) March 31, December 30, September 30, July 1, April 1, December 31, October 1, July 2, April 2,
More informationUpdated to reflect new accounting policy changes and quarterly presentation on Television business reported as discontinued operations.
Updated reporting Philips Group Updated to reflect new accounting policy changes and quarterly presentation on Television business reported as discontinued operations. all the data included in this report
More informationDecember 31, 2017 January 1, 2017
CYPRESS SEMICONDUCTOR CORPORATION CONDENSED CONSOLIDATED BALANCE SHEETS (In thousands) (Unaudited) December 31, January 1, ASSETS Cash, cash equivalents and short-term investments $ 151,596 $ 120,172 Accounts
More informationGILAT SATELLITE NETWORKS LTD. CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS U.S. dollars in thousands (except share and per share data)
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (except share and per share data) 2016 2015 2016 2015 Audited Revenues $ 279,551 $ 197,543 $ 80,345 $ 67,682 Cost of revenues 204,061 143,318 56,147 47,181
More informationLUPIN INC. AND SUBSIDIARIES. Consolidated Financial Statements As of and for the Years Ended March 31, 2018 and 2017
LUPIN INC. AND SUBSIDIARIES Consolidated Financial Statements As of and for the Years Ended March 31, 2018 and 2017 TABLE OF CONTENTS Page Independent Auditor s Report 1 Consolidated Balance Sheets 2 Consolidated
More informationNon-GAAP Definitions Masimo
Non-GAAP Definitions Last Updated: May 2, 2018 Forward-Looking Statements Masimo Corporation ( Masimo, MASI, or the Company ) cautions you that statements included in this presentation that are not a description
More information1Q Performance Summary
1Q 2015 - Performance Summary Operational and Financial Highlights - 1Q 2015 Net profit up by +6.2% to Euros 128.5 million Income grows by +13.8% (+1.1% cc*) to Euros 908.4 million, driven by sales of
More informationUNISYS CORPORATION CONSOLIDATED STATEMENTS OF INCOME (Unaudited) (Millions, except per share data)
CONSOLIDATED STATEMENTS OF INCOME (Millions, except per share data) Revenue Services $592.6 $596.5 $2,328.2 $2,406.3 Technology 152.2 125.2 413.6 414.4 744.8 721.7 2,741.8 2,820.7 Costs and expenses Cost
More informationON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data)
ON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENTS OF OPERATIONS (in millions, except per share data) Quarter Ended Six Months Ended March 31, July 1, July 1, Revenue $ 1,338.0
More informationFirst Half of 2015 Performance Summary
First Half of 2015 Performance Summary Operational and Financial Highlights - 1H 2015 Net profit grows +16.3% to Euros 261.5 million and revenues increase +18% exceeding Euros 1,900 million The revenues
More informationON SEMICONDUCTOR CORPORATION AND SUBSIDIARIES UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data)
UNAUDITED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share data) Revenue $ 1,455.9 $ 1,377.6 $ 1,338.0 $ 2,833.5 $ 2,774.7 Cost of revenue (exclusive of amortization shown below) 900.9
More informationTrack Group Reports Fiscal 2017 Financial Results
FOR IMMEDIATE RELEASE December 20, 2017 Peter Poli Chief Financial Officer 877-260-2010 peter.poli@trackgrp.com Track Group Reports Fiscal 2017 Financial Results Revenue Up 9%, Adjusted EBITDA Up 82% and
More informationNon-GAAP Financial Measures. Third Quarter and First Nine Months of Fiscal
Non-GAAP Financial Measures Third Quarter and First Nine Months of Fiscal 2012 www.siemens.com To supplement Siemens Consolidated Financial Statements presented in accordance with International Financial
More informationCurrent Developments New GAAP Requirements and Effect on Accounting for Income Taxes
Current Developments New GAAP Requirements and Effect on Accounting for Income Taxes Greg Pfahl/John Monahan December 8, 2016 New Revenue Recognition Standard Replacing industry-specific guidance, the
More informationFirst Quarter 2016 Performance Summary
First Quarter 2016 Performance Summary Operational and Financial Highlights - 1Q 2016 Grifols' revenues increase by +5.6% to Euros 959 million, driven by growth of +10.9% for the Bioscience Division The
More informationFinancial Section. P. 44 Consolidated Balance Sheet. P. 46 Consolidated Statement of Income. P. 47 Consolidated Statement of Comprehensive Income
Financial Section P. 44 Consolidated Balance Sheet P. 46 Consolidated Statement of Income P. 47 Consolidated Statement of Comprehensive Income P. 48 Consolidated Statement of Changes in Equity P. 49 Consolidated
More informationDocuments Glossary of IP Terms/Financial
Documents Glossary of IP Terms/Financial ABATNA (Best Alternative to a Negotiated Agreement). Any negotiator should determine his or her BATNA before agreeing to any negotiated settlement. If the alternative
More informationJanuary 26, 2016 Media Contact: Dan Turner WILMINGTON, Del Investor Contact:
January 26, 2016 Media Contact: Dan Turner WILMINGTON, Del. 302-996-8372 daniel.a.turner@dupont.com Investor Contact: 302-774-4994 DuPont Reports 4Q and Full-Year Operating EPS of $0.27 and $2.77 Increasing
More informationCoherent, Inc. Consolidated Statement of Operations - GAAP
Consolidated Statement of Operations - GAAP (In thousands except percentages and per share data, unaudited) April 1, December 31, October 1, July 2, April 2, January 2, October 3, July 4, April 4, December
More informationFirst Quarter 2017 Earnings Results
First Quarter 2017 Earnings Results Performance Summary May 3, 2017 Legal Disclaimer The facts and figures contained in this report that do not refer to historical data are future projections and assumptions.
More informationExhibit F. Financial Projections
Exhibit F Financial Projections Financial Projections In connection with the Disclosure Statement, 1 the Debtors management team ( Management ) prepared financial projections ( Financial Projections )
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period
More informationQ Financial information
July 19, 2018 Q2 2018 Financial information Financial Information Contents 03 07 Key Figures 08 35 Interim Consolidated Financial Information (unaudited) 36 48 Supplemental Reconciliations and Definitions
More informationTENNANT COMPANY (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ ü] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the quarterly period
More informationCoherent, Inc. Consolidated Statement of Operations - GAAP
Consolidated Statement of Operations - GAAP (In thousands except percentages and per share data, unaudited) December 31, October 1, July 2, April 2, January 2, October 3, July 4, April 4, December 27,
More informationNon-GAAP Financial Measures Fourth Quarter and Fiscal 2009
www.siemens.com Fourth Quarter and Fiscal 2009 To supplement Siemens Consolidated Financial Statements presented in accordance with International Financial Reporting Standards, or IFRS, Siemens presents
More informationReynolds Group Holdings Limited
Reynolds Group Holdings Limited 2017 Results February 14, 2018 Disclaimer This presentation may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act
More informationUnderstanding Financial Statements and Their Effects on Enhancing Value
Understanding Financial Statements and Their Effects on Enhancing Value 2017 California/Western States Chapter Conference Todd Poling, Vantage Point Advisors Josh Edwards, Eureka Valuation Advisors Main
More informationACCO Brands Corporation Fourth Quarter 2008 Earnings Call. February 27, 2009
ACCO Brands Corporation Fourth Quarter 2008 Earnings Call February 27, 2009 Forward-Looking Statement & Reg. G This presentation contains statements which may constitute "forward-looking" statements as
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C FORM 10-Q
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (MARK ONE) QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE QUARTERLY PERIOD
More informationNon-GAAP Financial Measures Second Quarter and First Half of Fiscal 2010
www.siemens.com Second Quarter and First Half of Fiscal 2010 To supplement Siemens Consolidated Financial Statements presented in accordance with International Financial Reporting Standards, or IFRS, Siemens
More informationFourth Quarter 2015 Performance Summary
Fourth Quarter 2015 Performance Summary Operational and Financial Highlights - 2015 Grifols revenues grow by 17.3% to Euros 3,935 million, and net profit grows by 13.2% reaching Euros 532 million of the
More informationIQVIA Reports Third-Quarter 2018 Results and Updates Full-Year 2018 Guidance
News Release Contacts: Andrew Markwick, IQVIA Investor Relations (andrew.markwick@iqvia.com) +1.973.257.7144 Tor Constantino, IQVIA Media Relations (tor.constantino@iqvia.com) +1.484.567.6732 IQVIA Reports
More informationNon-GAAP Financial Measures
First Quarter and Fiscal 2011 www.siemens.com To supplement Siemens Consolidated Financial Statements presented in accordance with International Financial Reporting Standards, or IFRS, Siemens presents
More informationNew Japan Radio Co., Ltd. and Consolidated Subsidiaries
New Japan Radio Co., Ltd. and Consolidated Subsidiaries Consolidated Financial Statements for the Years Ended March 31, 2011 and 2010, and Independent Auditors' Report INDEPENDENT AUDITORS' REPORT To the
More informationGOODWILL IMPAIRMENT TESTING Comparison of IFRS v GAAP
1 GOODWILL IMPAIRMENT TESTING Comparison of IFRS v GAAP Georg Gollnow PriceWaterhouseCoopers Jim Catty International Association of Consultants Valuators and Analysts 2 Necessity The recent sharp decline
More informationFinancial and Non-financial Highlights Financial Section Consolidated Balance Sheet
Financial and Non-financial Highlights Financial Section Consolidated Balance Sheet Yokogawa Electric Corporation and its Consolidated Subsidiaries March 31, 2017 ASSETS (Note 1) Current Assets: Cash and
More informationQ Earnings Call. May 3, 2016
IMS Health Q1 2016 Earnings Call May 3, 2016 0 Legal This presentation should be viewed in conjunction with IMS Health s Q1 2016 earnings call Safe Harbor Statement This presentation ti includes forward-looking
More informationLife Sciences Accounting and Financial Reporting Update Interpretive Guidance on Revenue Recognition Under ASC 606
Life Sciences Accounting and Financial Reporting Update Interpretive Guidance on Revenue Recognition Under ASC 606 March 2017 Revenue Recognition Background In May 2014, the FASB 1 and IASB issued their
More informationMylan: Q EARNINGS August 8, Q Earnings All Results are Unaudited
Mylan: Q2 2018 EARNINGS August 8, 2018 Q2 2018 Earnings All Results are Unaudited Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to
More informationFourth Quarter 2016 Performance Summary
Fourth Quarter 2016 Performance Summary Operational and Financial Highlights - 2016 Net profit rises by +2.5% to Euros 545.5 million Recurring sales (excluding Raw Materials and Others) rise by +4.5% (+4.6%
More informationOctober 27, 2015 Media Contact: Dan Turner WILMINGTON, Del Investor Contact:
October 27, 2015 Media Contact: Dan Turner WILMINGTON, Del. 302-996-8372 daniel.a.turner@dupont.com Investor Contact: 302-774-4994 DuPont Reports 3Q Operating EPS of $0.13; YTD Operating EPS of $2.49 Cost
More informationRecurring revenue 36, , % Non recurring revenue 3, , %
Item 7. Management s Discussion and Analysis of Financial Condition and Results of Operations The following discussion of our results of operations and financial condition should be read together with
More informationMcGraw-Hill Education, Inc. Quarterly Report. As of March 31, 2017
McGraw-Hill Education, Inc. Quarterly Report As of March 31, 2017 INDEX TO THE CONSOLIDATED FINANCIAL STATEMENTS OF MCGRAW-HILL EDUCATION, INC. AND SUBSIDIARIES Page Number Special Note Regarding Forward-Looking
More informationON Semiconductor Reports Fourth Quarter and 2018 Annual Results
ON Semiconductor Reports Fourth Quarter and Annual Results For the fourth quarter of, highlights include: Revenue of $1,503.1 million Gross margin of 37.9 percent GAAP operating margin of 14.8 percent
More informationTEIKOKU ELECTRIC MFG. CO., LTD. Consolidated Financial Statements for the Year Ended March 31, 2016 and Independent Auditor's Report
TEIKOKU ELECTRIC MFG. CO., LTD. Consolidated Financial Statements for the Year Ended March 31, 2016 and Independent Auditor's Report TEIKOKU ELECTRIC MFG. CO., LTD. Consolidated Balance Sheet March 31,
More informationTENNANT COMPANY (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q [ ü] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR For the quarterly period
More informationThird Quarter Earnings November 8, 2018
Third Quarter Earnings November 8, 2018 Forward Looking Statements & Disclosures Forward Looking Statement: With the exception of the historical information contained in this presentation, the matters
More informationSECOND QUARTER 2017 EARNINGS RELEASE July 20, 2017
SECOND QUARTER 2017 EARNINGS RELEASE July 20, 2017 Forward Looking Statements Statements in this presentation that are not strictly historical, including any statements regarding events or developments
More informationThird Quarter 2016 Performance Summary
Third Quarter 2016 Performance Summary Operational and Financial Highlights - 9M 2016 Sales of the Bioscience Division grow by +6.5%, increasing Grifols revenues to EUR 2,951.7 million over EUR 1,000 million
More informationConsolidated Balance Sheets Consolidated Statements of Income...4. Consolidated Statements of Changes in Equity...5 6
Contents Consolidated Balance Sheets...2 3 Consolidated Statements of Income...4 Consolidated Statements of Changes in Equity...5 6 Consolidated Statements of Cash Flows...7 Notes to Consolidated Financial
More informationMasonite International Corporation Reports 2017 First Quarter Financial Results
Masonite International Corporation Reports 2017 First Quarter Financial Results 5/8/2017 TAMPA, Fla.--(BUSINESS WIRE)-- Masonite International Corporation ("Masonite" or "the Company") (NYSE: DOOR) today
More informationNEW JAPAN RADIO CO., LTD. For the fiscal year 2009, ended March 31, 2010
NEW JAPAN RADIO CO., LTD. Annual Report 2010 For the fiscal year 2009, ended March 31, 2010 Management s Discussion and Analysis [Overview of Performance] During the current consolidated fiscal year, we
More informationCONSOLIDATED BALANCE SHEET AND INCOME STATEMENT DECEMBER 31, 2012
CONSOLIDATED BALANCE SHEET AND INCOME STATEMENT DECEMBER 31, 2012 The Board of Directors meeting of February 20, 2013 adopted and authorized the publication of Safran s consolidated financial statements
More informationCISCO SYSTEMS, INC. (Exact name of registrant as specified in its charter)
(Mark One) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly
More informationVALUATION OF GOODWILL WITHIN THE FAMILY LAW CONTEXT
Special Issue 2008 Intangible Asset Valuation Insights Insights 3 VALUATION OF GOODWILL WITHIN THE FAMILY LAW CONTEXT Robert F. Reilly Valuation analysts are often called on to value goodwill as part of
More informationCSG SYSTEMS INTERNATIONAL, INC. DISCLOSURES FOR NON-GAAP FINANCIAL MEASURES
CSG SYSTEMS INTERNATIONAL, INC. DISCLOSURES FOR NON-GAAP FINANCIAL MEASURES Use of Non-GAAP Financial Measures and Limitations To supplement its condensed consolidated financial statements presented in
More informationEndo Health Solutions
Endo Health Solutions 3Q 2013 Earnings Report and A Compelling Combination: Endo Health Solutions and Paladin Labs November 5, 2013 Offer Language Disclosures This communication is not intended to and
More informationConference Call Brooks Automation First Quarter FY19 Financial Results. February 5, 2019
Conference Call Brooks Automation First Quarter FY19 Financial February 5, 2019 1 Safe Harbor Statement Safe Harbor Statement under the U.S. Private Securities Litigation Reform Act of 1995; certain matters
More informationNet sales $ 106, % $ 77, %$ 29, % Legacy business 82, , , Acquired business 24,
Media Contact: Mike Osborne Sparton Corporation Email: ir@sparton.com Office: (847) 762-5800 FOR IMMEDIATE RELEASE Sparton Corporation Reports Fiscal 2016 First Quarter Adjusted Earnings Per Share of $0.41
More informationRecro Pharma, Inc. (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A CURRENT REPORT Pursuant to Section 13 OR 15 (d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest
More informationCSP Inc. (Exact name of Registrant as specified in its charter)
United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended
More informationMylan Q Non-GAAP Reconciliations November 5, Q Earnings All Results are Unaudited
Mylan Q3 Non-GAAP Reconciliations November 5, Q3 Earnings All Results are Unaudited Non-GAAP Financial Measures This presentation includes the presentation and discussion of certain financial information
More informationAgroFresh Business Combination Summary
AgroFresh Business Combination Summary Safe Harbor In addition to historical information, this presentation may contain forward-looking statements within the meaning of the safe harbor provisions of the
More informationValuation of Intangible Assets including. Purchase Price Allocation :74. Purchase Price Allocation
CA Ravishu Shah Valuation of Intangible Assets including Purchase Price Allocation Investment in knowledge based/intangible assets is one of the key characteristics of modern economies. Every goods including
More informationON Semiconductor Reports Third Quarter 2018 Results
News Release Revenue of $1,541.7 million Gross margin of 38.7 percent GAAP operating margin of 15.7 percent and non-gaap operating margin of 17.8 percent Operating cash flow of $358.2 million and free
More informationFourth Quarter Results Fiscal Year 2018
Fourth Quarter Results Fiscal Year 2018 RPM INTERNATIONAL INC. 1 Consolidated Statements of Income: Fiscal Year 2018 ($ in thousands, except per share and percent data) Fiscal Year Ended May 31, % 2018
More informationQ Financial information 1 Q FINANCIAL INFORMATION
April 17, 2019 Q1 2019 Financial information 1 Q1 2019 FINANCIAL INFORMATION Financial Information Contents 03 05 Key Figures 06 32 Consolidated Financial Information (unaudited) 33 41 Supplemental Reconciliations
More informationSL Bidco B.V. Interim financial report for the period 1 January 30 June Table of contents
SL Bidco B.V. Interim financial report for the period 1 January 30 June 2018 Table of contents 1. Consolidated profit and loss account 2. Consolidated balance sheet 3. Consolidated condensed cash flow
More informationMomentive Performance Materials Inc. 22 Corporate Woods Blvd. Albany, NY 12211
Momentive Performance Materials Inc. 22 Corporate Woods Blvd. Albany, NY 12211 NEWS RELEASE FOR IMMEDIATE RELEASE Momentive Performance Materials Inc. Reports Fourth Quarter and Fiscal Year 2010 Results
More informationITURAN LOCATION AND CONTROL LTD. Consolidated Interim Financial Statements as of March 31, 2014
Consolidated Interim Financial Statements as of March 31, 2014 Consolidated Financial Statements as of March 31, 2014 Table of Contents Page Consolidated Financial Statements: Balance Sheets 2-3 Statements
More informationAccretive Solutions Q Quarterly Learning Series. Due Diligence Best Practices
Accretive Solutions Q3 2015 Quarterly Learning Series Due Diligence Best Practices Agenda Buy-side and Sell-side Due Diligence Due diligence what is it and why is it important Summary 2 3 Section 1 Buy-side
More informationThe J. M. Smucker Company
The J. M. Smucker Company Second Quarter Fiscal 2019 Earnings SUPPLEMENTARY INFORMATION November 28, 2018 Consolidated Results ($ in millions, except per share data) FY19 Q2 FY18 Q2 YoY Change Net Sales
More informationBIO-TECHNE CORPORATION (Exact name of registrant as specified in its charter)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March
More informationON Semiconductor Reports Fourth Quarter and 2017 Annual Results
News Release ON Semiconductor Reports Fourth Quarter and 2017 Annual Results For the fourth quarter of 2017, highlights include: Revenue of $1,377.5 million GAAP gross margin of 37.3 percent and non-gaap
More informationITURAN LOCATION AND CONTROL LTD. Consolidated Interim Financial Statements as of March 31, 2013
Consolidated Interim Financial Statements as of March 31, 2013 Consolidated Financial Statements as of March 31, 2013 Table of Contents Page Consolidated Financial Statements: Balance Sheets 2-3 Statements
More informationIntertape Polymer Group Reports 2018 Second Quarter Results
NEWS RELEASE FOR IMMEDIATE DISTRIBUTION Intertape Polymer Group Reports 2018 Second Quarter Results Quarterly revenue increased 18.5% to $249.1 million Quarterly IPG Net Earnings increased $4.9 million
More informationInternational Glossary of Business Valuation Terms
International Glossary of Business Valuation Terms To enhance and sustain the quality of business valuations for the benefit of the profession and its clientele, the below identified societies and organizations
More informationBottomline Technologies Reconciliation to Non GAAP Measures Three Months Ended June 30, 2013
Reconciliation to Measures Three Months Ended June 30, 2013 Non Cash Amortization of Equity Based Integration Restructuring Interest GAAP Intangible Assets Compensation Related Expenses Expenses Expense
More informationation erials nt Mat ese Pr or lementalestvin Supp
Supplemental Investor Presentation Materials DENTSPLY International, Inc. Third Quarter 2014 Earnings Supplemental Materials October 29, 2014 2 Forward Looking Statements This presentation contains forward-looking
More informationHoughton Mifflin Harcourt Company Consolidated Balance Sheets
Consolidated Balance Sheets (in thousands of dollars, except share information) 2017 2016 Assets Current assets Cash and cash equivalents $ 148,979 $ 226,102 Short-term investments 86,449 80,841 Accounts
More informationReynolds Group Holdings Limited
Reynolds Group Holdings Limited Q2 2017 Results August 2, 2017 Disclaimer This presentation may contain forward-looking statements as that term is defined in the Private Securities Litigation Reform Act
More informationUNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C FORM 10-Q. For the quarterly period ended September 30, 2018
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly
More informationFORM 6-K. CGG (Translation of registrant s name into English)
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934 For the month
More informationMylan Q EARNINGS November 5, Q Earnings All Results are Unaudited
Mylan Q3 EARNINGS November 5, Q3 Earnings All Results are Unaudited Forward-Looking Statements This presentation contains forward-looking statements. These statements are made pursuant to the safe harbor
More informationThe Stephan Co. Fourth Quarter Report December 31, 2017 Page 1
Page 1 The Stephan Co. Fourth Quarter Report December 31, 2017 Table of Contents Consolidated Condensed Balance Sheets 3 Consolidated Condensed Statements of Operations for the three months ended December
More informationOne of the major applications of Equity Valuation is the Private companies valuation. Private companies valuation can be applied:
One of the major applications of Equity Valuation is the Private companies valuation. Private companies valuation can be applied: To value a Start up operations of Public companies. To estimate a value
More informationTransfer Pricing and Business Restructurings
Transfer Pricing and Business Restructurings Streamlining all the way Edited by Anuschka Bakker IBFD Foreword Acknowledgements Abbreviations and Common References v ix xi Part A Setting the Scene Chapter
More informationFLEX RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
FLEX RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES (In thousands, except per share amounts) Q1 FY17 Q2 FY17 Q3 FY17 Q4 FY17 Q1 FY18 Q2 FY18 GAAP gross profit $ 405,995 6.9% $ 313,691 5.2% $ 416,455
More informationManagement s Disucussion and Analysis
Management s Disucussion and Analysis [Overview of Performance] During the current consolidated fiscal year, the Japanese economy weakened due to deteriorating business performance and employment conditions
More informationNet sales $267.3 $258.2 $524.0 $507.3 Cost of goods sold Gross profit
Unaudited Consolidated Statements of Operations Three Months Ended Six Months Ended June 30, June 30, (in millions, except per share data) 2006 2005 2006 2005 Net sales $267.3 $258.2 $524.0 $507.3 Cost
More information